US Broker Ratings

CVS Health Corporation (CVS) Stock Analysis: A 25% Upside Potential with Strong Buy Ratings

CVS Health Corporation (NYSE: CVS), a stalwart in the healthcare sector, continues to capture investor attention with its robust market presence and compelling upside potential. With a market capitalization of..

RadNet, Inc. (RDNT) Stock Analysis: A Healthcare Play with 22.76% Upside Potential

RadNet, Inc. (NASDAQ: RDNT) has established itself as a formidable player in the healthcare sector, particularly within the diagnostics and research industry. Headquartered in Los Angeles, California, RadNet operates an..

Stevanato Group S.p.A. (STVN) Stock Analysis: Unveiling a 19.49% Potential Upside for Investors

Stevanato Group S.p.A. (NYSE: STVN), a prominent player in the healthcare sector, is garnering attention from individual investors due to its robust potential upside of 19.49%. As a leader in..

Biogen Inc. (BIIB) Stock Analysis: Exploring a 29% Upside Potential in the Healthcare Sector

Biogen Inc. (NASDAQ: BIIB) stands as a prominent player in the healthcare sector, particularly within the realm of drug manufacturing. With a market capitalization of $19.51 billion, this Massachusetts-based biotech..

Axsome Therapeutics, Inc. (AXSM) Stock Analysis: Unpacking a 59% Potential Upside with Promising CNS Therapies

Axsome Therapeutics, Inc. (NASDAQ: AXSM) is drawing attention in the biotechnology sector with its innovative approach to treating central nervous system (CNS) disorders. As the company stands at the forefront..

Cytokinetics, Incorporated (CYTK) Stock Report: Unpacking a Potential 124.61% Upside in the Biotech Arena

In the dynamic world of biotechnology, Cytokinetics, Incorporated (NASDAQ: CYTK) emerges as an intriguing player, particularly for investors with an appetite for high-growth potential. With its focus on groundbreaking muscle..

United Therapeutics Corporation (UTHR) Stock Analysis: Exploring a 19.54% Potential Upside

United Therapeutics Corporation (NASDAQ: UTHR), a key player in the healthcare sector, is making waves in the stock market with a potential upside of 19.54%. With a market capitalization of..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: Exploring a Potential 58% Upside in Healthcare Innovations

Lantheus Holdings, Inc. (NASDAQ: LNTH), a prominent player in the healthcare sector, is not just about diagnostics and therapeutics; it’s about promising growth potential. With a market capitalization of $5.64..

Zoetis Inc. (ZTS) Investor Outlook: Strong Buy Ratings and 14.25% Potential Upside

As an investor considering Zoetis Inc. (ZTS), the global leader in animal health solutions, there are several compelling reasons to keep this stock on your radar. With a current market..

ICON plc (ICLR) Stock Analysis: A 27.62% Potential Upside Amidst Healthcare Sector Volatility

ICON plc (NASDAQ: ICLR) stands out in the healthcare sector, particularly in the diagnostics and research industry, with an impressive market capitalization of $11.05 billion. Based in Dublin, Ireland, the..

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: Exploring the 52% Upside Potential

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a prominent player in the biotechnology sector, is capturing investor attention with its potential for significant upside. Specializing in novel therapeutics for metabolic dysfunction-associated steatohepatitis..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: A Biotech Gem with 109% Potential Upside

Investors with an eye on the biotechnology sector might find Sarepta Therapeutics, Inc. (NASDAQ: SRPT) an intriguing opportunity, particularly given its substantial potential upside of 109.16% to an average target..

Bausch + Lomb Corporation (BLCO) Stock Analysis: Exploring a 22% Potential Upside Amidst Healthcare Market Challenges

Bausch + Lomb Corporation (BLCO), a storied name in the healthcare sector, continues to navigate the complexities of the medical instruments and supplies industry. With roots tracing back to 1853,..

Labcorp Holdings Inc. (LH) Stock Analysis: Navigating a 7.85% Potential Upside Amidst a Strong Buy Consensus

Labcorp Holdings Inc. (NYSE: LH) stands as a significant player in the healthcare sector, specifically within the Diagnostics & Research industry. With a robust market capitalization of $21.26 billion, Labcorp..

Charles River Laboratories (CRL) Stock Analysis: Evaluating Growth Potential Amidst Diagnostic Sector Challenges

Charles River Laboratories International, Inc. (NYSE: CRL) is a prominent player in the healthcare sector, specifically within the diagnostics and research industry. Founded in 1947 and headquartered in Wilmington, Massachusetts,..

Haleon plc (HLN) Stock Analysis: Exploring Its 4.54% Potential Upside and Strategic Market Position

Haleon plc (HLN), a prominent player in the healthcare sector, has been making waves in the drug manufacturing industry with its impressive array of consumer healthcare products. As a UK-based..

Blueprint Medicines Corporation (BPMC) Stock Analysis: Navigating Biotech Growth with 55.5% Revenue Surge

Blueprint Medicines Corporation (NASDAQ: BPMC) stands out in the biotechnology sector, not just for its innovative approach to precision therapy, but also for its impressive 55.5% revenue growth, which sets..

Guardant Health, Inc. (GH) Stock Analysis: Navigating a 23.67% Potential Upside in the Dynamic Diagnostics Sector

Guardant Health, Inc. (NASDAQ: GH) stands out as a pivotal player in the rapidly evolving field of precision oncology. With a market capitalization of $5.95 billion, the company is at..

BrightSpring Health Services (BTSG) Stock Analysis: Strong Buy Ratings and a 12.55% Upside Potential

BrightSpring Health Services, Inc. (NYSE: BTSG), a key player in the Health Information Services industry, has been catching the eye of investors with its robust buy ratings and promising future..

Walgreens Boots Alliance (WBA) Stock Analysis: A Deep Dive into Healthcare Retail’s 8.89% Dividend Yield

Walgreens Boots Alliance, Inc. (NASDAQ: WBA) is a prominent player in the healthcare sector, specifically in pharmaceutical retailing. With its expansive presence across the United States and international markets, Walgreens..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds